BioSpace News Archive

Drug Development

Enterome to Present Clinical Data on EO2463 in B-cell Lymphoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Enterome announced that clinical data from the ongoing Phase 1/2 trial of EO2463 in monotherapy and in combination with lenalidomide and/or rituximab in indolent non-Hodgkin lymphoma will be presented at 2024 American Society of Clinical Oncology Annual Meeting, to take place May 31 - June 4, in Chicago, Illinois.

April 25, 2024
·
3 min read
Business

West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend

West Pharmaceutical Services, Inc. announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance.

April 25, 2024
·
13 min read
Business

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, reported business highlights and financial results for the first quarter ended March 31, 2024.

April 25, 2024
·
22 min read
Business

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance

Three regulatory approvals: new Dupixent indications in the US and Japan and Beyfortus in Japan.

April 25, 2024
·
2 min read
MEDIROM Healthcare Technologies Inc. Announces March 2024 Key Performance Indicators (KPIs)

MEDIROM Healthcare Technologies Inc., a holistic healthcare company based in Japan, announced its major Key Performance Indicators, or KPIs, updated for the month of March 2024.

April 25, 2024
·
11 min read